產(chǎn)品搜索
產(chǎn)品分類(lèi)
相關(guān)文章
- 從“腫瘤免疫療法”發(fā)展,看“單抗、CAR-T”任重而道遠(yuǎn)!
- 你知道ATCC細(xì)胞如何解凍嗎?
- 是激活還是沉默?基因表達(dá)的新路徑
- 【產(chǎn)品推介】T細(xì)胞活化篩選模型
- 為什么STR鑒定對(duì)于ATCC細(xì)胞系來(lái)說(shuō)很重要
- 喝熱茶或使食管癌風(fēng)險(xiǎn)增加5倍
- PIM-1激酶抑制劑細(xì)胞篩選模型
- ANG TIE2:重塑千億血管靶向治療市場(chǎng),“血管-免疫”協(xié)同治療革命
- PNAS:腫瘤細(xì)胞或可“拆用”間充質(zhì)干細(xì)胞來(lái)促進(jìn)乳腺癌復(fù)發(fā)
- 腫瘤細(xì)胞分裂“制動(dòng)系統(tǒng)”相關(guān)基因分析
聯(lián)系我們
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73255CSF3R S783fs/BaF3

- 詳細(xì)內(nèi)容
CBP73255 | |
I. Introduction | |
Cell Line Name: | CSF3R S783fs/BaF3 |
Host Cell: | Ba/F3 |
Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
II.Background | |
CSF3R S783fs results in a change in the amino acid sequence of the Csf3r protein beginning at aa 783 of 836, likely resulting in premature truncation of the functional protein (UniProt.org). S783fs does not result in increased Stat3 activation (PMID: 23656643, PMID: 24403076), however, results in increased Src activation and transformation in cell culture (PMID: 23656643), and therefore, is predicted to result in a gain of Csf3r protein function. | |
III. Representative Data | |
1.WB of CSF3R S783fs/BaF3 | |
2. Anti-proliferation assay | |
Figure 2. Anti-proliferation assay of three reference compounds on the CSF3R S783fs/BaF3. |